Austrianova
PrivateLast Round
VC Round
Mar 1, 2023
Company Overview
Austrianova operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a VC Round in March 2023.
Austrianova is a biotechnology company that provides cell encapsulation technology and services for the development of novel therapies and products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Austrianova Comparables
Compare Austrianova with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ALTuCELL | 80% | |
| Vicapsys Life Sciences Inc | 77% | |
| Encellin | 76% |
For institutional investors. Book with your work email.
Austrianova Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 1, 2023 | ||||
| VC Round | Jul 7, 2021 | ||||
| Post-IPO Equity Facility | Apr 22, 2021 | ||||
| VC Round | May 21, 2007 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Austrianova Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Global Emerging Markets | Post-IPO Equity Facility |
| Checkmate Capital | VC Round |
| Ryan Group Holdings | VC Round |
| UntroD Capital Japan Inc. | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 19, 2025
Klothonova formed to develop klotho-based cell therapies.
- Sep 19, 2025
Partnered with Avant Technologies to form Klothonova.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 7, 2026
Austrianova and Ospedale San Raffaele Srl collaborate to evaluate Austrianova's encapsulation technology with OSR's stem cell-derived beta cells for insulin-dependent diabetes in Nevada on Oct 7th '26.
- attends_eventSep 24, 2026
Austrianova attends the Second Annual Klotho Conference in Florida in Sep '26' and presents its encapsulated-cell approach to sustained α-Klotho delivery.
For institutional investors. Book with your work email.
Austrianova Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Austrianova's valuation, stock price, and market status.
Is Austrianova a public or private company?
Austrianova is a private company.
What is the current stock price of Austrianova?
Austrianova is a private company, so its shares have no public market price. Caplight tracks Austrianova's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Austrianova worth (valuation)?
Valuation information for Austrianova is not publicly available.
Can I buy Austrianova stock?
Austrianova shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Austrianova's last funding round?
Austrianova's most recent funding round was VC Round on March 1, 2023.
Who are the main investors in Austrianova?
Key investors in Austrianova include Global Emerging Markets, Checkmate Capital, Ryan Group Holdings, UntroD Capital Japan Inc..
Will Austrianova IPO soon?
No public IPO plans have been announced for Austrianova.
How can I track Austrianova secondary market activity?
Caplight tracks bids, offers, and trades in Austrianova's shares on secondary markets.